Medicare Enrolled

Dr. Anan Faidi, MD

Endocrinology · Stockton, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
930 N CENTER ST, Stockton, CA 95202
2099483000
In practice since 2006 (20 years)
NPI: 1609840479 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Faidi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Faidi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Faidi

Dr. Anan Faidi is an endocrinology specialist in Stockton, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Faidi performed 2,119 Medicare services across 1,380 unique beneficiaries.

Between the years covered by Open Payments, Dr. Faidi received a total of $73,284 from 54 pharmaceutical and/or device companies across 984 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Faidi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 29% volume in CA $73,284 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,119
Medicare services
Top 29% in CA for endocrinology
1,380
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~106 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,071 $93 $226
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
353 $67 $103
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
275 $40 $374
Ultrasound of arm and leg arteries
This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries.
144 $62 $192
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
141 $63 $153
New patient office visit, complex (60-74 min) 65 $170 $429
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
43 $117 $342
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
27 $131 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$73,284
Total received (2018-2024)
Avg $10,469/year across 7 years
Top 6% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
984
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$60,144 (82.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,140 (17.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,545
2023
$1,432
2022
$2,219
2021
$2,947
2020
$4,579
2019
$19,218
2018
$41,345

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$261
Boehringer Ingelheim Pharmaceuticals, Inc.
$244
Amgen Inc.
$226
Lilly USA, LLC
$190
Almatica Pharma LLC
$172
Antares Pharma, Inc.
$61
SANOFI-AVENTIS U.S. LLC
$47
Corcept Therapeutics
$46
Radius Health, Inc.
$44
ABBVIE INC.
$39
Dexcom, Inc.
$34
BETA BIONICS, INC.
$27
Xeris Pharmaceuticals, Inc.
$25
Verity Pharmaceuticals Inc.
$24
Ascensia Diabetes Care Us Inc.
$21
Novartis Pharmaceuticals Corporation
$20
Astellas Pharma US Inc
$18
Ascendis Pharma Inc
$17
Abbott Laboratories
$17
Kyowa Kirin, Inc.
$14
Top 3 companies account for 47.3% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$36,976
SANOFI-AVENTIS U.S. LLC
$23,572
Novo Nordisk Inc
$2,803
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,051
Lilly USA, LLC
$1,489
AstraZeneca Pharmaceuticals LP
$1,169
Radius Health, Inc.
$640
Corcept Therapeutics
$604
Abbott Laboratories
$578
Amgen Inc.
$501
Becton, Dickinson and Company
$211
Novartis Pharmaceuticals Corporation
$200
Antares Pharma, Inc.
$199
Medtronic, Inc.
$181
Almatica Pharma LLC
$172
Merck Sharp & Dohme Corporation
$142
Shire North American Group Inc
$137
ASCEND Therapeutics US, LLC
$127
GENZYME CORPORATION
$105
LifeScan, Inc.
$89
Alexion Pharmaceuticals, Inc.
$88
MannKind Corporation
$88
DEXCOM, INC.
$87
Horizon Therapeutics plc
$86
Amarin Pharma Inc.
$65
RECORDATI_RARE_DISEASES_INC.
$63
Xeris Pharmaceuticals, Inc.
$62
Esperion Therapeutics, Inc.
$58
AbbVie, Inc.
$58
Medtronic MiniMed, Inc.
$56
Bayer HealthCare Pharmaceuticals Inc.
$54
Mannkind Corporation
$53
Embecta Corp.
$53
LIFESCAN, INC.
$49
ABBVIE INC.
$39
Dexcom, Inc.
$34
Supernus Pharmaceuticals, Inc.
$27
BETA BIONICS, INC.
$27
Regeneron Healthcare Solutions, Inc.
$25
Companion Medical, Inc.
$25
Verity Pharmaceuticals Inc.
$24
Ascensia Diabetes Care Us Inc.
$21
Nevro Corp.
$20
Acerus Pharmaceuticals Corporation
$20
CeQur Corporation
$20
Averitas Pharma Inc.
$18
Astellas Pharma US Inc
$18
Ascendis Pharma Inc
$17
OPKO Pharmaceuticals, LLC
$16
Strongbridge US INC.
$16
E.R. Squibb & Sons, L.L.C.
$16
Kyowa Kirin, Inc.
$14
Insulet Corporation
$13
AbbVie Inc.
$11
Top 3 companies account for 86.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BINOSTO · CAMZYOS · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom G6 Transmitter · ENTRESTO · ESTROGEL · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · Korlym · LEQVIO · Levemir · MINIMED 770G · MOUNJARO · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · Natesto · OT Verio Reflect "One Touch Meter and Strips" · OTREXUP · Omnia · Omnipod · OneTouch · OneTouch Verio Reflect · Ozempic · PRALUENT · Prolia · QUTENZA · RETEVMO · RYBELSUS · Rayaldee · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tlando · Tresiba · Tymlos · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · iLet Bionic Pancreas
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for endocrinology in CA.

Looking for an endocrinology specialist in Stockton?
Compare endocrinologists in the Stockton area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
14
Per 100K population
1.8
County median income
$88,531
Nearest hospital
ST JOSEPH'S MEDICAL CENTER OF STOCKTON
1.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Faidi is a clinical cardiology specialist, with above-average Medicare volume (top 29% in CA), with speaking/promotional industry engagement in the top 6% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Faidi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Faidi performed 1,071 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Faidi receive payments from pharmaceutical companies?
Yes. Dr. Faidi received a total of $73,284 from 54 companies across 984 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Faidi's costs compare to other endocrinologists in Stockton?
Dr. Faidi's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Faidi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →